Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

2.

Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation.

Rachmawati NM, Fukudome K, Tsuneyoshi N, Bahrun U, Tsukamoto H, Yanagibashi T, Nagai Y, Takatsu K, Ohta S, Kimoto M.

Int Immunol. 2013 Feb;25(2):117-28. doi: 10.1093/intimm/dxs096. Epub 2012 Oct 17.

PMID:
23075507
3.

Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex.

Bahrun U, Kimoto M, Tsukamoto H, Tsuneyoshi N, Kohara J, Fukudome K.

Hybridoma (Larchmt). 2007 Dec;26(6):393-9.

PMID:
18158784
4.

Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction.

Tsuneyoshi N, Kohara J, Bahrun U, Saitoh S, Akashi S, Gauchat JF, Kimoto M, Fukudome K.

Cell Immunol. 2006 Nov;244(1):57-64. Epub 2007 Apr 8.

PMID:
17420011
5.

Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex.

Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M.

Clin Vaccine Immunol. 2006 Oct;13(10):1131-6.

6.

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment.

Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, Takatsu K, Kincade PW.

Immunity. 2006 Jun;24(6):801-12.

7.

Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling.

Ohta S, Bahrun U, Tanaka M, Kimoto M.

Biochem Biophys Res Commun. 2004 Oct 22;323(3):1103-8.

PMID:
15381113

Supplemental Content

Loading ...
Support Center